Incidence of treatment-emergent adverse events in Parkinson's Disease patients according to baseline body mass index: Post-hoc analysis from double-blind combined BIPARK-I and II data
暂无分享,去创建一个
E. Tolosa | W. Poewe | A. Lees | J. Ferreira | P. Soares-da-Silva | F. Rocha | R. Costa | F. Ikedo | M. Diogo
[1] W. Poewe,et al. Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial , 2017, JAMA neurology.
[2] Werner Poewe,et al. Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial , 2016, The Lancet Neurology.